Gotham Asset Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Gotham Asset Management's RVMD Position: Q3 2026 in Review
Gotham Asset Management increased its Revolution Medicines (RVMD) stake by 12% in Q3 2026, buying an estimated $2.76M and bringing the position to 134,651 shares worth $27.6M. The position accounts for 0.05% of the portfolio, ranked #534.
Gotham Asset Management first reported a position in RVMD in Q3 2025 and has held it in 5 quarters since. 760 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Gotham Asset Management held 134,651 shares of Revolution Medicines worth $27.6M as of Q3 2026.
- Gotham Asset Management bought 13,949 Revolution Medicines shares in Q3 2026, an estimated $2.76M.
- Revolution Medicines made up 0.05% of Gotham Asset Management's portfolio in Q3 2026, its #534 holding.
- Gotham Asset Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 5 quarters since.
- 760 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.